SU

SUSMED, Inc.

Develops digital therapeutics (DTx) and AI systems to streamline clinical development.

4263 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区日本橋本町三丁目7番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SUSMED, Inc. is a research and development-focused company that promotes digital medicine under the concept of "sustainable medicine." The company's business is centered on two main pillars: the development of therapeutic smartphone applications (Digital Therapeutics/DTx) for various diseases, such as its government-approved app for insomnia, and the provision of digital systems to support and streamline clinical development for pharmaceutical companies. SUSMED leverages technologies, including AI and blockchain, to enhance the efficiency of clinical trials and create new medical solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-26 08:32
Regulatory News Service
確認書
Japanese 8.6 KB
2025-09-26 08:31
Annual Report
有価証券報告書-第10期(2024/07/01-2025/06/30)
Japanese 1.9 MB
2025-02-14 07:30
Interim Report
確認書
Japanese 8.6 KB
2025-02-14 07:30
Interim Report
半期報告書-第10期(2024/07/01-2025/06/30)
Japanese 230.1 KB
2024-09-27 08:03
Post-Annual General Meeting Information
臨時報告書
Japanese 29.8 KB
2024-09-27 08:02
Governance Information
内部統制報告書-第9期(2023/07/01-2024/06/30)
Japanese 22.5 KB
2024-09-27 08:01
Registration Form
確認書
Japanese 8.6 KB
2024-09-27 08:01
Annual Report
有価証券報告書-第9期(2023/07/01-2024/06/30)
Japanese 1.9 MB
2024-05-10 08:01
Regulatory News Service
確認書
Japanese 8.6 KB
2024-05-10 08:00
Quarterly Report
四半期報告書-第9期第3四半期(2024/01/01-2024/03/31)
Japanese 181.5 KB
2024-02-14 07:01
Report Publication Announcement
確認書
Japanese 8.6 KB
2024-02-14 07:00
Quarterly Report
四半期報告書-第9期第2四半期(2023/10/01-2023/12/31)
Japanese 206.2 KB
2023-11-10 09:05
Regulatory News Service
確認書
Japanese 8.6 KB
2023-11-10 09:03
Quarterly Report
四半期報告書-第9期第1四半期(2023/07/01-2023/09/30)
Japanese 183.3 KB
2023-09-29 08:04
Post-Annual General Meeting Information
臨時報告書
Japanese 26.0 KB

Automate Your Workflow. Get a real-time feed of all SUSMED, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SUSMED, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HANATOUR SERVICE INC. Logo
South Korea's top travel firm offering package tours and custom trips for B2C & B2B clients.
South Korea 039130
Hanmi Science Co.,Ltd Logo
A holding company managing R&D-focused pharmaceutical, API, and medical device firms.
South Korea 008930
Heidelberg Pharma AG Logo
Develops cancer therapies using its proprietary ATAC Antibody-Drug Conjugate technology.
Germany HPHA
HighCo Logo
Data marketing firm offering digital solutions for brands & retailers to influence shopper behavior.
France HCO
H.I.S. Co., Ltd. Logo
A major Japanese travel agency providing global tour packages, lodging, and transport.
Japan 9603
Hit Co., Ltd. Logo
Specialized OOH advertising firm providing digital & static billboards in high-visibility areas.
Japan 378A
HLB Therapeutics Co.,Ltd. Logo
Develops innovative drugs for rare eye diseases and brain tumors, with vaccine logistics.
South Korea 115450
HONYAKU Center Inc. Logo
Provides industrial translation and interpreting for patent, legal, and corporate clients.
Japan 2483
A holding company for advanced materials, AI/data solutions, mobility, and global logistics.
South Korea 487570
Human Metabolome Technologies, Inc. Logo
A leader in metabolomics, providing CE-MS analysis to support R&D in biotech, pharma, and food.
Japan 6090

Talk to a Data Expert

Have a question? We'll get back to you promptly.